BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16087328)

  • 1. Karyometry in the early detection and chemoprevention of intraepithelial lesions.
    Ranger-Moore J; Alberts DS; Montironi R; Garcia F; Davis J; Frank D; Brewer M; Mariuzzi GM; Bartels HG; Bartels PH
    Eur J Cancer; 2005 Sep; 41(13):1875-88. PubMed ID: 16087328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials.
    Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet R; Sigman CC
    Cancer Res; 1994 Apr; 54(7 Suppl):2015s-2024s. PubMed ID: 8137331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endpoint markers for clinical trials of chemopreventive agents derived from the properties of epithelial precancer (intraepithelial neoplasia) measured by computer-assisted image analysis.
    Boone CW; Kelloff GJ
    Cancer Surv; 1998; 32():133-47. PubMed ID: 10489626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of intraepithelial neoplasia in humans with implications for cancer chemoprevention strategy.
    Boone CW; Kelloff GJ; Steele VE
    Cancer Res; 1992 Apr; 52(7):1651-9. PubMed ID: 1551096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surrogate end-point biomarkers in chemopreventive drug development.
    Kelloff GJ; Sigman CC; Hawk ET; Johnson KM; Crowell JA; Guyton KZ
    IARC Sci Publ; 2001; 154():13-26. PubMed ID: 11220652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker end-points in cancer chemoprevention trials.
    Boone CW; Kelloff GJ
    IARC Sci Publ; 1997; (142):273-80. PubMed ID: 9354926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lycopene as a chemopreventive agent in the treatment of high-grade prostate intraepithelial neoplasia.
    Mohanty NK; Saxena S; Singh UP; Goyal NK; Arora RP
    Urol Oncol; 2005; 23(6):383-5. PubMed ID: 16301113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput genomic technology in research and clinical management of breast cancer. Molecular signatures of progression from benign epithelium to metastatic breast cancer.
    Rennstam K; Hedenfalk I
    Breast Cancer Res; 2006; 8(4):213. PubMed ID: 16895590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation.
    Hurlstone DP; Sanders DS; Lobo AJ; McAlindon ME; Cross SS
    Endoscopy; 2005 Dec; 37(12):1186-92. PubMed ID: 16329015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The convergent development of molecular-targeted drugs for cancer treatment and prevention.
    Lippman SM; Heymach JV
    Clin Cancer Res; 2007 Jul; 13(14):4035-41. PubMed ID: 17634526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward.
    Kelloff GJ; Lippman SM; Dannenberg AJ; Sigman CC; Pearce HL; Reid BJ; Szabo E; Jordan VC; Spitz MR; Mills GB; Papadimitrakopoulou VA; Lotan R; Aggarwal BB; Bresalier RS; Kim J; Arun B; Lu KH; Thomas ME; Rhodes HE; Brewer MA; Follen M; Shin DM; Parnes HL; Siegfried JM; Evans AA; Blot WJ; Chow WH; Blount PL; Maley CC; Wang KK; Lam S; Lee JJ; Dubinett SM; Engstrom PF; Meyskens FL; O'Shaughnessy J; Hawk ET; Levin B; Nelson WG; Hong WK;
    Clin Cancer Res; 2006 Jun; 12(12):3661-97. PubMed ID: 16778094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostatic intraepithelial neoplasia and other changes during promotion and progression.
    Pretlow TG; Nagabhushan M; Pretlow TP
    Pathol Res Pract; 1995 Sep; 191(9):842-9. PubMed ID: 8606863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG; Gardner WA
    Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue architecture analysis in prostate cancer and its precursors: An innovative approach to computerized histometry.
    Bartels PH; Montironi R; Duval da Silva V; Hamilton PW; Thompson D; Vaught L; Bartels HG
    Eur Urol; 1999; 35(5-6):484-91. PubMed ID: 10325510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifocal high grade prostatic intraepithelial neoplasia is a significant risk factor for prostatic adenocarcinoma.
    Merrimen JL; Jones G; Walker D; Leung CS; Kapusta LR; Srigley JR
    J Urol; 2009 Aug; 182(2):485-90; discussion 490. PubMed ID: 19524976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finasteride decreases the risk of prostatic intraepithelial neoplasia.
    Thompson IM; Lucia MS; Redman MW; Darke A; La Rosa FG; Parnes HL; Lippman SM; Coltman CA
    J Urol; 2007 Jul; 178(1):107-9; discussion 110. PubMed ID: 17499284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care.
    Epstein JI; Herawi M
    J Urol; 2006 Mar; 175(3 Pt 1):820-34. PubMed ID: 16469560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis.
    Henrique R; Jerónimo C; Teixeira MR; Hoque MO; Carvalho AL; Pais I; Ribeiro FR; Oliveira J; Lopes C; Sidransky D
    Mol Cancer Res; 2006 Jan; 4(1):1-8. PubMed ID: 16446401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of disease: high-grade prostatic intraepithelial neoplasia and other proposed preneoplastic lesions in the prostate.
    Montironi R; Mazzucchelli R; Lopez-Beltran A; Cheng L; Scarpelli M
    Nat Clin Pract Urol; 2007 Jun; 4(6):321-32. PubMed ID: 17551536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathological evidence for an association of inflammation with ductal pin-like lesions but not with ductal adenocarcinoma in the prostate of the noble rat.
    Bernoulli J; Yatkin E; Laakso A; Anttinen M; Bosland M; Vega K; Kallajoki M; Santti R; Pylkkänen L
    Prostate; 2008 May; 68(7):728-39. PubMed ID: 18302197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.